NOX 0.00% 10.0¢ noxopharm limited

Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer, page-27

  1. 386 Posts.
    lightbulb Created with Sketch. 37
    Are you serious ? are we investing in the same company ?

    To have one drug trial is extremely difficult to achieve, we have 3 on the go at the same time, and to reach phase 2 in DARRT in an incredible achievement in it's own right.

    CEP-2 trial results should come out pretty soon, in my opinion going by previous trials they should have a good indication on efficacy by now, so time will tell the fact that there has not been any adverse results reported on any of the trials is extremely positive in my opinion.

    Any of the above trials can be sold if someone is interested in them at this stage.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.